Glass House Brands (GLAS) Interest Expenses (2020 - 2026)
Glass House Brands (GLAS) posted quarterly Interest Expenses of $1.3 million for Q1 2026, up 187.09% quarter-over-quarter from -$1.5 million in Q4 2025.
Glass House Brands (GLAS) Interest Expenses (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Interest Expenses for 7 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses changed N/A year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $3.5 million (down 13.59% YoY), while the FY2025 annual figure was $41.0 million, up 2.77% from the prior year.
- Interest Expenses advanced to $1.3 million in Q1 2026 per GLAS's latest filing, from -$1.5 million in the prior quarter.
- Across five years, Interest Expenses topped out at $48.4 million in Q4 2023 and bottomed at -$1.5 million in Q4 2025.
- Historically, Interest Expenses has averaged $7.7 million across 5 years, with a median of $1.9 million in 2025.
- Annual changes were most pronounced in 2023 — Interest Expenses surged 2134.27% — and 2025, when it tumbled 103.73%.
- Glass House Brands' Interest Expenses stood at $2.2 million in 2022, then soared by 2134.27% to $48.4 million in 2023, then declined by 17.65% to $39.9 million in 2024, then slumped by 103.73% to -$1.5 million in 2025, then jumped by 187.09% to $1.3 million in 2026.
- Business Quant data shows GLAS's Interest Expenses at $1.3 million in Q1 2026, -$1.5 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Glass House Brands | 835.49 Mn | 816.93 Mn | 15.77 Mn | 628,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | -1.49 Mn |
| Dec 31, 2025 | -1.49 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.92 Mn |
| Jun 30, 2025 | 1.92 Mn |
| Dec 31, 2024 | 39.89 Mn |
| Dec 31, 2024 | 39.89 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Jun 30, 2024 | 2.59 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 48.44 Mn |
| Dec 31, 2023 | 48.44 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.60 Mn |